| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $94K | -72.8% |
| Cost of Revenue | $85K | -70.4% |
| Gross Profit | $10K | -83.9% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $155K | -43.6% |
| Operating Income | -$270K | +18.3% |
| Interest Expense | $25K | -84.5% |
| Pre-tax Income | -$334K | +33.1% |
| Net Income | -$334K | +37.4% |
| EPS (Basic) | $0.00 | — |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24K | +9.5% |
| Accounts Receivable | $2K | -98.4% |
| Current Assets | $106K | -42.4% |
| Total Assets | $361K | -41.8% |
| Current Liabilities | $2.1M | -29.9% |
| Long-term Debt | $14K | +0.0% |
| Total Liabilities | $3.2M | -26.8% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -744.5% |
| Capital Expenditures | $762 | — |
| Investing Cash Flow | -$762 | +94.0% |
| Financing Cash Flow | $542K | +3793.7% |
| Free Cash Flow | -$1.1M | — |
| Stockholders' Equity |
| -$2.9M |
| +24.3% |